🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the repeatability and reproducibil...
Status
Suspended
Location
London Vision Clinic
Start Date
2022-09-01
Trial ID
NCT03473847
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested
This study proposes to use a new instrument (AO-OCT/AF: adaptive optics - o...
Status
Active Not Recruiting
Location
New York Eye and Ear Infirmary of Mount Sinai
Start Date
2023-09-06
Trial ID
NCT03963817
Treatments Being Tested
Evaluate the repeatability and reproducibility of the RTVue-XR for measurin...
Status
Completed
Location
Baylor College of Medicine
Start Date
2015-10
Trial ID
NCT02600546
Evaluate the ability and accuracy of the Retinal Health Monitoring System -...
Status
Withdrawn
Location
Retinal Consultants Medical Group, Inc
Start Date
2020-04
Trial ID
NCT04428242
Neuroretinal damage in diabetes produces functional abnormalities such as t...
Status
Completed
Location
Department Of Ophthalmology
Start Date
2013-01
Trial ID
NCT02620644
Treatments Being Tested
The purpose of this study is to assess the tolerability and efficacy of ran...
Status
Completed
Location
Texas Retina Associates
Start Date
2014-09-23
Trial ID
NCT02222610
Treatments Being Tested
This study seeks to compare dexamethasone implant with rescue intravitreal ...
Status
Unknown
Location
Wills Eye Retina Service
Start Date
2011-09
Trial ID
NCT01581151
Treatments Being Tested
Patients with retinal detachment do not always recover good visual function...
Status
Completed
Location
CHU Besançon
Start Date
2011-11
Trial ID
NCT01767038
Treatments Being Tested
The Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (ME...
Status
Completed
Location
Jules Stein Eye Institute, UCLA
Start Date
2017-03-09
Trial ID
NCT02623426